PSMA-PET/MR scan for repeat prostate biopsy
Part of Cancer, Kidney & urinary clinical trials.
This trial tests if a special PET/MR scan can help guide a second prostate biopsy in men with rising PSA. It may reduce the need for unnecessary biopsies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man age 40 or older.
- Your PSA level is between 4 and 20 ng/mL.
- You have not had prostate surgery or radiation therapy.
- You do not have active prostatitis or a bleeding disorder.
- You have no severe anal or rectal problems and are not allergic to local numbing medicine.
- You are able to tolerate a prostate biopsy procedure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a special scan called PSMA PET can help diagnose prostate cancer in men whose MRI results are not clear. It may help avoid unnecessary biopsies.
This study tests whether a special scan (PSMA PET/MRI) combined with a standard MRI can better detect prostate cancer. It is for men who have not had a biopsy yet and are suspected of having prostate cancer.
This study tests a new way to guide prostate biopsies using a special scan (PSMA PET/CT) that highlights suspicious areas. If you need a biopsy because of high PSA and abnormal MRI, this approach might help make the biopsy more accurate.
This trial tests if combining a PSMA PET scan with an MRI can better detect clinically significant prostate cancer than MRI alone. It may help men who have not had a prostate biopsy before and have certain risk factors.
This trial looks at using a PSMA PET/CT scan to better re-check cancer activity in men whose PSA has started rising after prostate removal. If you qualify, the scan may help doctors choose the next best treatment step.
This trial compares two imaging techniques—PSMA PET/CT and MRI—to see which one better finds and outlines prostate cancer tumors. You'll receive both scans to help doctors understand which method works best for newly diagnosed prostate cancer.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.